Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manif...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4d31ac84f8ca48baabd3a110d5c4cedf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4d31ac84f8ca48baabd3a110d5c4cedf2021-11-25T16:56:33ZSex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study10.3390/brainsci111113982076-3425https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3425/11/11/1398https://doaj.org/toc/2076-3425Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manifests differently in males and females, including abnormalities in the dopamine system that are also seen in <i>Fmr1</i>-knockout (KO) mice. We investigated sex differences in dopamine signaling in <i>Fmr1</i>-KO mice in response to L-stepholidine, a dopamine D1 receptor agonist and D2 receptor antagonist. We found significant sex differences in basal levels of phosphorylated protein kinase A (p-PKA) and glycogen synthase kinase (GSK)-3β in wild type mice that were absent in <i>Fmr1</i>-KO mice. In wild-type mice, L-stepholidine increased p-PKA in males but not female mice, decreased p-GSK-3 in female mice and increased p-GSK-3 in male mice. Conversely, in <i>Fmr1</i>-KO mice, L-stepholidine increased p-PKA and p-GSK-3β in females, and decreased p-PKA and p-GSK-3β in males.Anlong JiangLe WangJustin Y. D. LuAmy FreemanCharlie CampbellPing SuAlbert H. C. WongFang LiuMDPI AGarticleFragile X syndromesex differenceL-stepholidinedopamine signaling<i>Fmr1</i> knockoutD1 receptorNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain Sciences, Vol 11, Iss 1398, p 1398 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Fragile X syndrome sex difference L-stepholidine dopamine signaling <i>Fmr1</i> knockout D1 receptor Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
Fragile X syndrome sex difference L-stepholidine dopamine signaling <i>Fmr1</i> knockout D1 receptor Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Anlong Jiang Le Wang Justin Y. D. Lu Amy Freeman Charlie Campbell Ping Su Albert H. C. Wong Fang Liu Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
description |
Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manifests differently in males and females, including abnormalities in the dopamine system that are also seen in <i>Fmr1</i>-knockout (KO) mice. We investigated sex differences in dopamine signaling in <i>Fmr1</i>-KO mice in response to L-stepholidine, a dopamine D1 receptor agonist and D2 receptor antagonist. We found significant sex differences in basal levels of phosphorylated protein kinase A (p-PKA) and glycogen synthase kinase (GSK)-3β in wild type mice that were absent in <i>Fmr1</i>-KO mice. In wild-type mice, L-stepholidine increased p-PKA in males but not female mice, decreased p-GSK-3 in female mice and increased p-GSK-3 in male mice. Conversely, in <i>Fmr1</i>-KO mice, L-stepholidine increased p-PKA and p-GSK-3β in females, and decreased p-PKA and p-GSK-3β in males. |
format |
article |
author |
Anlong Jiang Le Wang Justin Y. D. Lu Amy Freeman Charlie Campbell Ping Su Albert H. C. Wong Fang Liu |
author_facet |
Anlong Jiang Le Wang Justin Y. D. Lu Amy Freeman Charlie Campbell Ping Su Albert H. C. Wong Fang Liu |
author_sort |
Anlong Jiang |
title |
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
title_short |
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
title_full |
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
title_fullStr |
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
title_full_unstemmed |
Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study |
title_sort |
sex differences in dopamine receptor signaling in <i>fmr1</i> knockout mice: a pilot study |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf |
work_keys_str_mv |
AT anlongjiang sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT lewang sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT justinydlu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT amyfreeman sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT charliecampbell sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT pingsu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT alberthcwong sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy AT fangliu sexdifferencesindopaminereceptorsignalinginifmr1iknockoutmiceapilotstudy |
_version_ |
1718412834876948480 |